Sector | Healthcare |
Industry | - |
Day Range | 473.00 | 485.00 |
52-Wk Range | 298.20 | 483.00 |
Last Close | 476.60 |
Mkt Cap (m) | 8,508.24 |
Dividend yield | 0.6% |
ISIN | FR0000038259 |
Volume | 26,833 |
Exchange Venue | PAR |
Eurofins Scientific SE is engaged providing food, environment and pharmaceutical products testing. It also provides agroscience, genomics, discovery pharmacology and central laboratory services; and also specialty clinical diagnostic testing.
Price/Earning | 60.71 |
Price/Book | 3.17 |
Price/Sales | 2.07 |
P/CF | 15.62 |
Rev Growth (3 year avg) | 24.70 |
EPS Growth (3 year avg) | 0.21 |
Operating Margin % | 8.93 |
Net Margin % | 5.92 |
Return on Equity | 8.76 |
Debt/Equity | 1.18 |
en 31/12/2017 |
EUR | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
Revenue (m) | 1,226 | 1,410 | 1,950 | 2,537 | 2,971 | 3,781 |
Operating Income (m) | 112 | 133 | 205 | 280 | 287 | 338 |
Net Income (m) | 72 | 79 | 87 | 174 | 217 | 224 |
Basic EPS | 3.54 | 5.15 | 5.71 | 10.88 | 10.49 | 9.91 |
Avg. Diluted Shares Outstanding (m) | 16 | 16 | 16 | 17 | 18 | 18 |
EUR | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
Current Assets (m) | 645 | 621 | 1,424 | 1,579 | 1,827 | 1,705 |
Non Current Assets (m) | 852 | 1,252 | 2,276 | 2,550 | 4,006 | 5,500 |
Total Assets (m) | 1,497 | 1,873 | 3,700 | 4,129 | 5,832 | 7,205 |
Current Liabilities (m) | 339 | 452 | 775 | 710 | 1,452 | 1,451 |
Total Liabilities (m) | - | - | - | - | - | - |
Total Equity (m) | 388 | 656 | 957 | 1,627 | 2,443 | 2,669 |
EUR | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
Operating Cash Flows (m) | 169 | 212 | 291 | 372 | 405 | 544 |
Capital Expenditure (m) | -100 | -135 | -169 | -200 | -246 | -364 |